We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
AUM
$4.05B
AUM Growth
+$38.8M
Cap. Flow
-$116M
Cap. Flow %
-2.87%
Top 10 Hldgs %
18.39%
Holding
733
New
60
Increased
226
Reduced
298
Closed
60

Top Sells

Rank Stock Value
1
CLX icon
Clorox
CLX
+$24.7M
2
DIS icon
Walt Disney
DIS
+$19.9M
3
TGT icon
Target
TGT
+$19M
4
DRI icon
Darden Restaurants
DRI
+$18.6M
5
CI icon
Cigna
CI
+$17.6M

Sector Composition

Rank Sector Weight
1 Healthcare 17.77%
2 Technology 14.35%
3 Financials 11.2%
4 Industrials 10.03%
5 Communication Services 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EAT icon
76
Brinker International
EAT
$9B
$17.2M 0.42%
340,663
+314,479
+1,201% +$15.8M
ESRX
77
DELISTED
Express Scripts Holding Company
ESRX
$16.8M 0.41%
238,016
-18,063
-7% -$1.35M
WCG
78
DELISTED
Wellcare Health Plans, Inc.
WCG
$16.6M 0.41%
141,934
+127,569
+888% +$14.2M
COF icon
79
Capital One
COF
$129B
$16.5M 0.41%
230,244
+475
+0.2% +$32.6K
VRTX icon
80
Vertex Pharmaceuticals
VRTX
$122B
$16.4M 0.41%
+188,245
New +$17.8M
CHKP icon
81
Check Point Software Technologies
CHKP
$13.1B
$16.4M 0.41%
211,415
-9,972
-5% -$773K
SWK icon
82
Stanley Black & Decker
SWK
$14.4B
$16.4M 0.4%
133,117
+124,249
+1,401% +$15M
DE icon
83
Deere & Co
DE
$162B
$16M 0.4%
187,429
-1,189
-0.6% -$97.3K
CAH icon
84
Cardinal Health
CAH
$53.2B
$15.5M 0.38%
199,374
-68,282
-26% -$5.52M
BXP icon
85
Boston Properties
BXP
$11.4B
$15.5M 0.38%
113,410
-310
-0.3% -$43K
APD icon
86
Air Products & Chemicals
APD
$66.8B
$15.2M 0.38%
+109,127
New +$15.1M
TMX
87
DELISTED
Terminix Global Holdings, Inc.
TMX
$15M 0.37%
666,421
+528
+0.1% +$13.3K
FDC
88
DELISTED
First Data Corporation
FDC
$14.7M 0.36%
+1,116,969
New +$14.4M
ENH
89
DELISTED
Endurance Specialty Holdings Ltd
ENH
$14.3M 0.35%
219,066
-4,581
-2% -$304K
PNC icon
90
PNC Financial Services
PNC
$99.2B
$13.9M 0.34%
154,697
-3,660
-2% -$314K
KEY icon
91
KeyCorp
KEY
$24.2B
$13.9M 0.34%
1,139,852
+74,919
+7% +$897K
SKT icon
92
Tanger
SKT
$4.71B
$13.9M 0.34%
355,643
-95
-0% -$3.84K
SUI icon
93
Sun Communities
SUI
$15.3B
$13.1M 0.32%
167,043
-39,741
-19% -$3.08M
BRSL
94
Brightstar Lottery PLC
BRSL
$1.87B
$13M 0.32%
535,244
+16,714
+3% +$369K
DHI icon
95
D.R. Horton
DHI
$40.7B
$13M 0.32%
430,897
-139,586
-24% -$4.48M
BAH icon
96
Booz Allen Hamilton
BAH
$8.22B
$13M 0.32%
410,543
-57,150
-12% -$1.74M
WBD icon
97
Warner Bros
WBD
$63.9B
$12.9M 0.32%
480,135
-940
-0.2% -$24.1K
FFIV icon
98
F5
FFIV
$22.1B
$12.7M 0.31%
+102,062
New +$12.4M
OSK icon
99
Oshkosh
OSK
$8.82B
$12.7M 0.31%
226,846
+105,336
+87% +$5.55M
LH icon
100
Labcorp
LH
$25.9B
$12.7M 0.31%
107,192
+6,045
+6% +$712K

Similar funds

Boston Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Boston Advisors held 733 positions worth $4.05B, up 0.97% from $4.01B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Advisors's Q3 2016 filing shows 60 new, 226 increased, 298 reduced and 60 closed positions. Its largest new stake was Vertex Pharmaceuticals: 188,245 shares worth $16.4M. The largest sale was Clorox, an estimated $24.7M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Financials.

  • Boston Advisors's largest Q3 2016 buy was Vertex Pharmaceuticals: 188,245 shares worth $16.4M.
  • Boston Advisors added most to AbbVie in Q3 2016, an estimated $27.2M increase.
  • Boston Advisors's biggest Q3 2016 reduction was Clorox, cutting an estimated $24.7M.
  • Boston Advisors fully exited Cadence Design Systems in Q3 2016, selling an estimated $14.4M.
  • Boston Advisors's ten largest holdings make up 18% of its $4.05B portfolio in Q3 2016.
  • Boston Advisors opened 60 new positions and closed 60 in Q3 2016.
  • Boston Advisors's portfolio value rose 0.97% quarter-over-quarter to $4.05B.

Based on Boston Advisors's 13F filing for Q3 2016, filed 25 Oct 2016.